217 related articles for article (PubMed ID: 34337076)
21. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.
Lin JH; Tu SH; Chen LC; Huang CC; Chang HL; Cheng TC; Chang HW; Wu CH; Wu HC; Ho YS
Breast Cancer Res Treat; 2018 Nov; 172(1):45-59. PubMed ID: 30054830
[TBL] [Abstract][Full Text] [Related]
22. Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells.
Maxwell T; Lee KS; Kim S; Nam KS
Int J Oncol; 2018 Apr; 52(4):1339-1349. PubMed ID: 29436614
[TBL] [Abstract][Full Text] [Related]
23. Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.
Treeck O; Wackwitz B; Haus U; Ortmann O
Gynecol Oncol; 2006 Aug; 102(2):292-9. PubMed ID: 16443261
[TBL] [Abstract][Full Text] [Related]
24. Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma.
Ma J; Guo Y; Chen S; Zhong C; Xue Y; Zhang Y; Lai X; Wei Y; Yu S; Zhang J; Liu W
BMC Cancer; 2014 Mar; 14():172. PubMed ID: 24612549
[TBL] [Abstract][Full Text] [Related]
25. Celastrol Exerts Cardioprotective Effect in Rheumatoid Arthritis by Inhibiting TLR2/HMGB1 Signaling Pathway-Mediated Autophagy.
Lu X; Gong S; Wang X; Hu N; Pu D; Zhang J; Wang Y; Luo J; An Q; Ju B; He L
Int Arch Allergy Immunol; 2021; 182(12):1245-1254. PubMed ID: 34428765
[TBL] [Abstract][Full Text] [Related]
26. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Anbalagan M; Carrier L; Glodowski S; Hangauer D; Shan B; Rowan BG
Breast Cancer Res Treat; 2012 Apr; 132(2):391-409. PubMed ID: 21509526
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells.
Lee YJ; Won AJ; Lee J; Jung JH; Yoon S; Lee BM; Kim HS
Int J Med Sci; 2012; 9(10):881-93. PubMed ID: 23155362
[TBL] [Abstract][Full Text] [Related]
28. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
29. Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death.
Wang X; Wei S; Zhao Y; Shi C; Liu P; Zhang C; Lei Y; Zhang B; Bai B; Huang Y; Zhang H
Cancer Lett; 2017 Jan; 385():128-136. PubMed ID: 27810405
[TBL] [Abstract][Full Text] [Related]
30. Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells.
Cai Z; Qian B; Pang J; Tan ZB; Zhao K; Lei T
Curr Med Sci; 2022 Apr; 42(2):387-396. PubMed ID: 35419676
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of apoptotic and autophagic induction by a novel synthetic C-1 analogue of 7-deoxypancratistatin in human breast adenocarcinoma and neuroblastoma cells with tamoxifen.
Ma D; Collins J; Hudlicky T; Pandey S
J Vis Exp; 2012 May; (63):. PubMed ID: 22688195
[TBL] [Abstract][Full Text] [Related]
32. Celastrol induces lipophagy via the LXRα/ABCA1 pathway in clear cell renal cell carcinoma.
Zhang CJ; Zhu N; Long J; Wu HT; Wang YX; Liu BY; Liao DF; Qin L
Acta Pharmacol Sin; 2021 Sep; 42(9):1472-1485. PubMed ID: 33303989
[TBL] [Abstract][Full Text] [Related]
33. Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
Ronghe A; Chatterjee A; Bhat NK; Padhye S; Bhat HK
Oncotarget; 2016 Aug; 7(32):51747-51762. PubMed ID: 27351134
[TBL] [Abstract][Full Text] [Related]
34. Novel quinazolinone MJ‑33 induces AKT/mTOR‑mediated autophagy‑associated apoptosis in 5FU‑resistant colorectal cancer cells.
Ha HA; Chiang JH; Tsai FJ; Bau DT; Juan YN; Lo YH; Hour MJ; Yang JS
Oncol Rep; 2021 Feb; 45(2):680-692. PubMed ID: 33416156
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
36. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of autophagy strengthens celastrol-induced apoptosis in human pancreatic cancer in vitro and in vivo models.
Zhao X; Gao S; Ren H; Huang H; Ji W; Hao J
Curr Mol Med; 2014 May; 14(4):555-63. PubMed ID: 24730520
[TBL] [Abstract][Full Text] [Related]
38. S-Adenosylmethionine-mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells.
Cave DD; Desiderio V; Mosca L; Ilisso CP; Mele L; Caraglia M; Cacciapuoti G; Porcelli M
J Cell Physiol; 2018 Feb; 233(2):1370-1383. PubMed ID: 28518408
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
[TBL] [Abstract][Full Text] [Related]
40. Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy.
Lee HW; Jang KS; Choi HJ; Jo A; Cheong JH; Chun KH
BMB Rep; 2014 Dec; 47(12):697-702. PubMed ID: 24667175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]